VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $327,000 | +15.1% | 58,062 | -16.1% | 0.00% | – |
| Q1 2024 | $284,000 | +73.2% | 69,180 | +78.4% | 0.00% | – |
| Q4 2023 | $164,000 | -48.6% | 38,785 | -47.5% | 0.00% | – |
| Q3 2023 | $319,000 | -35.9% | 73,809 | -2.1% | 0.00% | – |
| Q2 2023 | $498,000 | +6.6% | 75,409 | +9.8% | 0.00% | – |
| Q1 2023 | $467,000 | +191.9% | 68,648 | +216.2% | 0.00% | – |
| Q4 2022 | $160,000 | -23.8% | 21,711 | +2.2% | 0.00% | – |
| Q3 2022 | $210,000 | -8.3% | 21,235 | +1.3% | 0.00% | – |
| Q2 2022 | $229,000 | -3.0% | 20,955 | +0.2% | 0.00% | – |
| Q1 2022 | $236,000 | -30.6% | 20,906 | -3.3% | 0.00% | – |
| Q4 2021 | $340,000 | -8.6% | 21,622 | -0.3% | 0.00% | – |
| Q3 2021 | $372,000 | -17.5% | 21,680 | +3.5% | 0.00% | – |
| Q2 2021 | $451,000 | +43.6% | 20,947 | +0.1% | 0.00% | – |
| Q1 2021 | $314,000 | -35.5% | 20,928 | -43.5% | 0.00% | – |
| Q4 2020 | $487,000 | +23.9% | 37,034 | -8.8% | 0.00% | – |
| Q3 2020 | $393,000 | -4.4% | 40,598 | +13.2% | 0.00% | – |
| Q2 2020 | $411,000 | +105.5% | 35,854 | +85.7% | 0.00% | – |
| Q1 2020 | $200,000 | +545.2% | 19,303 | +940.0% | 0.00% | – |
| Q4 2019 | $31,000 | +34.8% | 1,856 | +6.1% | 0.00% | – |
| Q3 2019 | $23,000 | -14.8% | 1,750 | -7.4% | 0.00% | – |
| Q2 2019 | $27,000 | -22.9% | 1,890 | -0.6% | 0.00% | – |
| Q1 2019 | $35,000 | -52.7% | 1,902 | -33.0% | 0.00% | – |
| Q4 2018 | $74,000 | +19.4% | 2,840 | +6.3% | 0.00% | – |
| Q3 2018 | $62,000 | +24.0% | 2,671 | +1.1% | 0.00% | – |
| Q2 2018 | $50,000 | -18.0% | 2,643 | -27.6% | 0.00% | – |
| Q1 2018 | $61,000 | +3.4% | 3,649 | -6.0% | 0.00% | – |
| Q4 2017 | $59,000 | -54.3% | 3,880 | -46.1% | 0.00% | – |
| Q3 2017 | $129,000 | +126.3% | 7,194 | +104.7% | 0.00% | – |
| Q2 2017 | $57,000 | +16.3% | 3,515 | +0.3% | 0.00% | – |
| Q1 2017 | $49,000 | -34.7% | 3,506 | -25.1% | 0.00% | – |
| Q4 2016 | $75,000 | +29.3% | 4,680 | +33.7% | 0.00% | – |
| Q3 2016 | $58,000 | +107.1% | 3,500 | +40.0% | 0.00% | – |
| Q2 2016 | $28,000 | -67.8% | 2,500 | -76.0% | 0.00% | – |
| Q1 2016 | $87,000 | -10.3% | 10,400 | -0.6% | 0.00% | – |
| Q4 2015 | $97,000 | -31.7% | 10,462 | -17.2% | 0.00% | – |
| Q3 2015 | $142,000 | +54.3% | 12,628 | +73.9% | 0.00% | – |
| Q2 2015 | $92,000 | +16.5% | 7,260 | -14.6% | 0.00% | – |
| Q1 2015 | $79,000 | -35.2% | 8,500 | 0.0% | 0.00% | – |
| Q4 2014 | $122,000 | +47.0% | 8,500 | +6.2% | 0.00% | – |
| Q3 2014 | $83,000 | -35.7% | 8,000 | 0.0% | 0.00% | – |
| Q2 2014 | $129,000 | +3.2% | 8,000 | +3.9% | 0.00% | – |
| Q1 2014 | $125,000 | +101.6% | 7,700 | +54.0% | 0.00% | – |
| Q4 2013 | $62,000 | -91.6% | 5,000 | -92.5% | 0.00% | -100.0% |
| Q3 2013 | $734,000 | +118.5% | 67,084 | +61.3% | 0.00% | – |
| Q2 2013 | $336,000 | – | 41,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |